CARE Ratings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 3:56 pm

Quick Insight

CARE Ratings Ltd, with a market cap of ₹4,976 Cr., is currently trading at ₹1,660 with a P/E ratio of 35.0. The company boasts a healthy ROE of 18.0% and ROCE of 24.6%, indicating efficient capital utilization. Operating at an OPM of 43% and an ICR of 92.77x, CARE Ratings demonstrates robust operational performance and strong debt-servicing capabilities. With significant institutional ownership (FIIs at 24.75% and DIIs at 27.50%) and a diverse shareholder base, including the public at 47.74%, the company enjoys broad investor confidence. The high P/BV ratio of 4.65x suggests a premium valuation, reflecting market optimism about future growth prospects.

Competitors of CARE Ratings Ltd

All Competitor Stocks of CARE Ratings Ltd

Quarterly Result

Last Updated: August 20, 2025, 12:25 pm

Below is a detailed analysis of the quarterly data for CARE Ratings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 94.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Mar 2025) to 94.00 Cr., marking a decrease of 16.00 Cr..
• For Expenses, as of Jun 2025, the value is 66.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 62.00 Cr. (Mar 2025) to 66.00 Cr., marking an increase of 4.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 47.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 19.00 Cr..
• For OPM %, as of Jun 2025, the value is 30.00%. The value appears to be declining and may need further review. It has decreased from 43.00% (Mar 2025) to 30.00%, marking a decrease of 13.00%.
• For Other Income, as of Jun 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 22.00 Cr..
• For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 29.00%, marking an increase of 3.00%.
• For Net Profit, as of Jun 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 17.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.61. The value appears to be declining and may need further review. It has decreased from 14.24 (Mar 2025) to 8.61, marking a decrease of 5.63.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 5:32 pm

Growth

Last Updated: September 5, 2025, 1:35 am

Balance Sheet

Last Updated: July 25, 2025, 3:26 pm

Below is a detailed analysis of the balance sheet data for CARE Ratings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 30.00 Cr..
• For Reserves, as of Mar 2025, the value is 776.00 Cr.. The value appears strong and on an upward trend. It has increased from 687.00 Cr. (Mar 2024) to 776.00 Cr., marking an increase of 89.00 Cr..
• For Borrowings, as of Mar 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 20.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 4.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 128.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 105.00 Cr. (Mar 2024) to 128.00 Cr., marking an increase of 23.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 958.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 842.00 Cr. (Mar 2024) to 958.00 Cr., marking an increase of 116.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 109.00 Cr. (Mar 2024) to 119.00 Cr., marking an increase of 10.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 134.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2024) to 134.00 Cr., marking an increase of 90.00 Cr..
• For Other Assets, as of Mar 2025, the value is 702.00 Cr.. The value appears strong and on an upward trend. It has increased from 683.00 Cr. (Mar 2024) to 702.00 Cr., marking an increase of 19.00 Cr..
• For Total Assets, as of Mar 2025, the value is 958.00 Cr.. The value appears strong and on an upward trend. It has increased from 842.00 Cr. (Mar 2024) to 958.00 Cr., marking an increase of 116.00 Cr..

Notably, the Reserves (776.00 Cr.) exceed the Borrowings (24.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for CARE Ratings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 33.77. This value is within the healthy range. It has increased from 28.17 (Mar 23) to 33.77, marking an increase of 5.60.
• For Diluted EPS (Rs.), as of Mar 24, the value is 33.67. This value is within the healthy range. It has increased from 28.17 (Mar 23) to 33.67, marking an increase of 5.50.
• For Cash EPS (Rs.), as of Mar 24, the value is 37.87. This value is within the healthy range. It has increased from 32.32 (Mar 23) to 37.87, marking an increase of 5.55.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 242.72. It has increased from 228.63 (Mar 23) to 242.72, marking an increase of 14.09.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 242.72. It has increased from 228.63 (Mar 23) to 242.72, marking an increase of 14.09.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 111.11. It has increased from 93.94 (Mar 23) to 111.11, marking an increase of 17.17.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 53.20. This value is within the healthy range. It has increased from 46.22 (Mar 23) to 53.20, marking an increase of 6.98.
• For PBIT / Share (Rs.), as of Mar 24, the value is 49.69. This value is within the healthy range. It has increased from 42.67 (Mar 23) to 49.69, marking an increase of 7.02.
• For PBT / Share (Rs.), as of Mar 24, the value is 49.12. This value is within the healthy range. It has increased from 42.34 (Mar 23) to 49.12, marking an increase of 6.78.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 34.36. This value is within the healthy range. It has increased from 28.77 (Mar 23) to 34.36, marking an increase of 5.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 33.67. This value is within the healthy range. It has increased from 28.12 (Mar 23) to 33.67, marking an increase of 5.55.
• For PBDIT Margin (%), as of Mar 24, the value is 47.88. This value is within the healthy range. It has decreased from 49.20 (Mar 23) to 47.88, marking a decrease of 1.32.
• For PBIT Margin (%), as of Mar 24, the value is 44.72. This value exceeds the healthy maximum of 20. It has decreased from 45.43 (Mar 23) to 44.72, marking a decrease of 0.71.
• For PBT Margin (%), as of Mar 24, the value is 44.20. This value is within the healthy range. It has decreased from 45.07 (Mar 23) to 44.20, marking a decrease of 0.87.
• For Net Profit Margin (%), as of Mar 24, the value is 30.92. This value exceeds the healthy maximum of 10. It has increased from 30.63 (Mar 23) to 30.92, marking an increase of 0.29.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 30.30. This value exceeds the healthy maximum of 20. It has increased from 29.93 (Mar 23) to 30.30, marking an increase of 0.37.
• For Return on Networth / Equity (%), as of Mar 24, the value is 14.01. This value is below the healthy minimum of 15. It has increased from 12.42 (Mar 23) to 14.01, marking an increase of 1.59.
• For Return on Capital Employeed (%), as of Mar 24, the value is 19.43. This value is within the healthy range. It has increased from 17.80 (Mar 23) to 19.43, marking an increase of 1.63.
• For Return On Assets (%), as of Mar 24, the value is 11.94. This value is within the healthy range. It has increased from 10.83 (Mar 23) to 11.94, marking an increase of 1.11.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.41. It has increased from 0.33 (Mar 23) to 0.41, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 24, the value is 8.57. This value exceeds the healthy maximum of 3. It has decreased from 10.19 (Mar 23) to 8.57, marking a decrease of 1.62.
• For Quick Ratio (X), as of Mar 24, the value is 8.57. This value exceeds the healthy maximum of 2. It has decreased from 10.19 (Mar 23) to 8.57, marking a decrease of 1.62.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 71.02 (Mar 23) to 0.00, marking a decrease of 71.02.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 63.07 (Mar 23) to 0.00, marking a decrease of 63.07.
• For Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 28.98 (Mar 23) to 0.00, marking a decrease of 28.98.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 36.93 (Mar 23) to 0.00, marking a decrease of 36.93.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 92.77. This value is within the healthy range. It has decreased from 137.04 (Mar 23) to 92.77, marking a decrease of 44.27.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 60.91. This value is within the healthy range. It has decreased from 86.31 (Mar 23) to 60.91, marking a decrease of 25.40.
• For Enterprise Value (Cr.), as of Mar 24, the value is 3,303.86. It has increased from 1,859.53 (Mar 23) to 3,303.86, marking an increase of 1,444.33.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 9.96. This value exceeds the healthy maximum of 3. It has increased from 6.67 (Mar 23) to 9.96, marking an increase of 3.29.
• For EV / EBITDA (X), as of Mar 24, the value is 20.80. This value exceeds the healthy maximum of 15. It has increased from 13.55 (Mar 23) to 20.80, marking an increase of 7.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 10.06. This value exceeds the healthy maximum of 3. It has increased from 6.84 (Mar 23) to 10.06, marking an increase of 3.22.
• For Retention Ratios (%), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 28.97 (Mar 23) to 0.00, marking a decrease of 28.97.
• For Price / BV (X), as of Mar 24, the value is 4.65. This value exceeds the healthy maximum of 3. It has increased from 2.84 (Mar 23) to 4.65, marking an increase of 1.81.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 10.06. This value exceeds the healthy maximum of 3. It has increased from 6.84 (Mar 23) to 10.06, marking an increase of 3.22.
• For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness